Revenue: QQ2 2025 of $61.092 million, YoY +13.64%, QoQ +1.08%. Gross Profit: $33.494 million, Gross Margin 54.83%, YoY Gross Profit +27.39%, QoQ +5.72%. Operating Income: -$39.578 million, Operating Margin -64.78%, YoY -14.48% on a QoQ basis down 14.48%. Net Income: -$38.668 million, Net Margin -63.29%, YoY -32.00% in QoQ terms. EBITDA: -$24.626 million, EBITDA Margin -40.31%. Earnings Per Share (Diluted): -$0.13, Weighted Average Shares (Diluted): 290.364 million. Cash Flow: Operating Cash Flow -$7.858 million; Capital Expenditures -$20.913 million; Free Cash Flow -$28.771 million. Cash Balance: End of period $166.629 million; Cash and Short-Term Investments (Total): $249.39 million; Net Cash Busy/Net Debt: Net Debt = -$124.315 million. Balance Sheet Highlights: Total Assets $658.351 million; Total Liabilities $185.104 million; Total Stockholders’ Equity $473.247 million; Deferred Revenue (Current) $64.523 million; Deferred Revenue (Non-Current) $11.969 million. Liquidity Ratios: Current Ratio 2.32, Quick Ratio 2.32, Cash Ratio 1.125. Profitability Metrics: Gross Margin ~54.8%, Operating Margin ~-64.8%, Net Margin ~-63.3%. Backlog/Def Revenue: Noted current deferred revenue of $64.523 million indicating revenue recognition timing dynamics.